Little Green PharmaASX:LGP Days Payable is 86.36 as of Mar. 2026, which is 19% below its 10-year median of 106.23. The stock has 3 warning signs investors should review. Among 920 Drug Manufacturers companies, Little Green Pharma ranks better than 62.28% on this metric.
The historical rank and industry rank for Little Green Pharma's Days Payable or its related term are showing as below:
ASX:LGP'
s Days Payable Range Over the Past 10 Years
Min: 90.2 Med: 106.23 Max: 482.73
Current: 111.3
During the past 7 years, Little Green Pharma's highest Days Payable was 482.73. The lowest was 90.20. And the median was 106.23.
ASX:LGP's Days Payable is ranked better than 62.28% of 920
companies
in the Drug Manufacturers industry
Industry Median: 90.835
vs ASX:LGP: 111.30
Little Green Pharma's Days Payable
declined
from Mar. 2025 (124.67) to Mar. 2026 (86.36).
It may suggest that Little Green Pharmaaccelerated paying its suppliers.
Little Green Pharma Days Payable Related Terms
Little Green Pharma Days Payable Historical Data
* Premium members only.
The historical data trend for Little Green Pharma's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Little Green Pharma's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Little Green Pharma Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Little Green Pharma's Days Payable distribution charts can be found below:
* The bar in red indicates where Little Green Pharma's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Little Green Pharma's Days Payable for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Little Green Pharma (ASX:LGP) has a Days Payable of 86.36 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Little Green Pharma and its competitors. This is 19% below median its historical median of 106.23. Over the past decade, Little Green Pharma's Days Payable has ranged from 90.20 to 482.73. According to the industry distribution chart, Little Green Pharma ranks #347 out of 920 companies in the Drug Manufacturers industry, placing it in the top 37.7%.
Is Little Green Pharma's Days Payable too high?
Little Green Pharma's current Days Payable of 86.36 is 19% below median its 10-year median of 106.23. Over the past 10 years, this metric has ranged from a low of 90.20 to a high of 482.73. The Drug Manufacturers industry median Days Payable is 90.84. Little Green Pharma's value of 86.36 is 4.9% below this industry median. Based on the distribution chart, Little Green Pharma ranks #347 out of 920 companies in the Drug Manufacturers industry, which is above the industry midpoint.
How does Little Green Pharma's Days Payable compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Little Green Pharma ranks #347 out of 920 companies for Days Payable. This puts Little Green Pharma in the upper half of its industry. The industry median Days Payable is 90.84. Little Green Pharma's value of 86.36 is 4.9% below this benchmark. Historically, Little Green Pharma's own Days Payable has ranged from 90.20 to 482.73 over the past decade. While the company's 10-year median is 106.23 vs. the industry median of 90.84, Little Green Pharma has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 90.84, based on 920 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Little Green Pharma's current Days Payable of 86.36 is 4.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Little Green Pharma and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.84 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Little Green Pharma's current Days Payable is 86.36, which is 19% below median its own 10-year median of 106.23. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Little Green Pharma stock overvalued right now?
Based on GuruFocus' analysis, Little Green Pharma (ASX:LGP) is currently considered Significantly Undervalued. The stock's GF Value™ is A$0.17, compared to a current price of A$0.06 — trading 62.4% below its estimated fair value. The current Days Payable is 86.36, which is 19% below median its 10-year median of 106.23 and 4.9% below the Drug Manufacturers industry median of 90.84. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Little Green Pharma (ASX:LGP), the current Days Payable is 86.36 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Little Green Pharma Ltd is engaged in the vertically integrated medicinal cannabis business. The business activities of the company include cultivation, production, research and development, manufacturing, and distribution of medicinal cannabis products. The company's two key types of products available at Little Green Pharma are oils (which are ingested) and flowers (which are usually inhaled through vaporizing). It offers LGP-branded medicinal cannabis oil products in the Australian and European markets. The Group is organized into two operating segments: Australia and Europe (cultivation, production and distribution of cannabis products to Australian and European customers).
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:LGP has been successfully added to your 